文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血管升压药对系统性炎症人体模型大循环与微循环的影响

Effect of Vasopressors on the Macro- and Microcirculation During Systemic Inflammation in Humans In Vivo.
PubMed 文献 · Shock · 2020-01-01
一句话结论在实验性内毒素血症健康男性中,去甲肾上腺素、去苯肾上腺素和血管升压素均不影响舌下微循环,仅血管升压素部分减轻LPS所致舒张压下降并稳定全身血管阻力。

该随机对照研究将40名健康男性志愿者分配至5小时输注去甲肾上腺素0.05 μg/kg/min(n=10)、去氧肾上腺素0.5 μg/kg/min(n=10)、血管升压素0.04 IU/min(n=10)或生理盐水(n=10),于静脉给予2 ng/kg脂多糖(LPS)前1小时开始。LPS给药影响所有大循环和微循环参数。LPS所致血压和全身血管阻力下降对低剂量去甲肾上腺素和去氧肾上腺素无反应,对血管升压素反应也较弱。仅血管升压素对PCA参数有影响,通过稳定全身血管阻力和心输出量减轻LPS所致舒张压下降。内毒素血症所致微血管血流和密度指数下降未受血管升压药治疗影响。

要点

  • 在实验性人类内毒素血症中,去甲肾上腺素0.05 μg/kg/min、去氧肾上腺素0.5 μg/kg/min和血管升压素0.04 IU/min均未影响舌下微循环血流和密度指数。
  • 仅血管升压素(0.04 IU/min)对PCA参数有影响,通过稳定全身血管阻力和心输出量减轻LPS所致舒张压下降。
  • LPS所致血压和全身血管阻力下降对低剂量去甲肾上腺素和去氧肾上腺素无反应,对血管升压素反应也较弱。
  • 研究为随机对照研究,40名健康男性志愿者,每组10人,血管升压药于LPS前1小时开始输注5小时。

适用人群与场景

  • 健康男性志愿者40名,随机分配至四组,每组10人。
  • 实验性人类内毒素血症模型:静脉给予2 ng/kg脂多糖(LPS)诱导系统性炎症。

处置流程与药物剂量

  • 去甲肾上腺素组:0.05 μg/kg/min静脉输注5小时,于LPS给药前1小时开始。
  • 去氧肾上腺素组:0.5 μg/kg/min静脉输注5小时,于LPS给药前1小时开始。
  • 血管升压素组:0.04 IU/min静脉输注5小时,于LPS给药前1小时开始。
  • 对照组:生理盐水输注。

研究设计与关键结果

  • 研究类型:随机对照研究;样本量40名健康男性志愿者,每组10人;人群:实验性人类内毒素血症健康男性。
  • 干预与对照:5小时输注去甲肾上腺素0.05 μg/kg/min、去氧肾上腺素0.5 μg/kg/min、血管升压素0.04 IU/min或生理盐水,于LPS前1小时开始。
  • 主要终点结果:LPS给药影响所有大循环和微循环参数;LPS所致血压和全身血管阻力下降对低剂量去甲肾上腺素和去氧肾上腺素无反应,对血管升压素反应也较弱。
  • 关键次要终点:仅血管升压素对PCA参数有影响,通过稳定全身血管阻力和心输出量减轻LPS所致舒张压下降;内毒素血症所致微血管血流和密度指数下降未受血管升压药治疗影响。

证据类型、等级与局限

  • 证据类型:随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:在高度受控的人类系统性炎症模型中,5小时输注不同血管升压药显示出对大循环血流动力学变量的不同影响,但不影响舌下微循环。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Comparing the effects of different vasopressors in septic shock patients is hampered by high heterogeneity and the fact that current guidelines dictate the use of norepinephrine. Herein, we studied the effects of three vasopressor agents, norepinephrine, phenylephrine, and vasopressin, on the macro- and microcirculation during experimental human endotoxemia, a standardized, controlled model of systemic inflammation in humans in vivo.

METHODS: We performed a randomized controlled study in which 40 healthy male volunteers were assigned to a 5-h infusion of either 0.05 μg/kg/min norepinephrine (n = 10), 0.5 μg/kg/min phenylephrine (n = 10), 0.04 IU/min vasopressin (n = 10), or saline (n = 10), starting 1 h before intravenous administration of 2 ng/kg lipopolysaccharide (LPS). The macrocirculation was monitored using arterial catheter-derived parameters with additional blood pressure waveform contour analysis (PCA) until 4.5 h following LPS administration. Sublingual microcirculatory density and flow were assessed using a handheld video microscope until 6 h post-LPS.

RESULTS: LPS administration affected all macrocirculatory and microcirculatory parameters. The LPS-induced decrease in blood pressure and systemic vascular resistance (SVR) was refractory to low-dose norepinephrine and phenylephrine, and to a lesser extent, to vasopressin. Only vasopressin exerted effects on PCA parameters compared with placebo, by mitigating the LPS-induced decrease in diastolic blood pressure by stabilizing SVR and cardiac output. The endotoxemia-induced decreased indices of microvascular flow and density were not influenced by vasopressor therapy.

CONCLUSIONS: In a highly controlled model of systemic inflammation in humans in vivo, a 5-h infusion of various vasopressors revealed distinctive effects on macrohemodynamic variables without affecting the sublingual microcirculation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. van Loon LM, Stolk RF, van der Hoeven JG, et al. Effect of Vasopressors on the Macro- and Microcirculation During Systemic Inflammation in Humans In Vivo. Shock. 2020. PMID: 31008870. doi:10.1097/SHK.0000000000001357

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。